Bayh-Dole Act Casting a Shadow Over New COVID-19 Medical Developments
November 05, 2020
Historically, circumstances under which a federal agency has requested transfer of patent title under the amended Bayh-Dole Act have been rare. However, times and circumstances have changed. On this episode, patent partner, Jeff Morton, discusses the possibility of a federal agency requesting transfer of title for a patent that covers COVID-19 antibody treatment.
The purpose of this podcast is to provide information on current topics of general interest and nothing herein shall be construed to create, offer, or memorialize the existence of an attorney-client relationship. The content should not be considered legal advice or opinion, because it may not apply to the specific facts of a particular matter. As guidance in areas is constantly changing and evolving, you should consider checking for updated guidance, or consult with legal counsel, before making any decisions. The opinions expressed during this podcast are the opinions of the individual only and do not reflect the opinions or position of Snell & Wilmer or any of its individual attorneys.